Cloud-Based Tool Automates the Design of Targeted Single-Cell DNA Custom Panels
In tandem, the company expands into Europe through partnerships with leading research and medical institutions to help them predict and prevent cancer relapse.
Read MorePosted by Steve Halasey | Mar 25, 2019 | Research |
In tandem, the company expands into Europe through partnerships with leading research and medical institutions to help them predict and prevent cancer relapse.
Read MorePosted by Steve Halasey | Mar 24, 2019 | Research |
To capture more instances of the potential for passing along inherited diseases, a study from Myriad Genetics recommends clarification of the current screening guidelines from health professional associations.
Read MorePosted by Chaunie Brusie | Mar 20, 2019 | Colorectal, Research |
The research found that younger patients were more likely than older patients to have certain genetic mutations and certain subtypes of colorectal cancer.
Read MorePosted by Chaunie Brusie | Mar 20, 2019 | Breast, Melanoma |
Study data demonstrate that about half of patients have clinically actionable mutations that are being missed.
Read MorePosted by Chaunie Brusie | Mar 14, 2019 | Cardiovascular, Leukemia |
The license encompasses both a novel method and bioinformatic tools that combine to improve the level of detection in NGS, allowing for the identification of ultrarare gene variants.
Read More